An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
Removing or preventing the formation of [Formula: see text]-synuclein aggregates is a plausible strategy against Parkinson’s disease. To this end, we have engineered the [Formula: see text]-wrapin AS69 to bind monomeric [Formula: see text]-synuclein with high affinity. In cultured cells, AS69 reduce...
Main Authors: | , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
eLife Sciences Publications Ltd
2019-08-01
|
丛编: | eLife |
主题: | |
在线阅读: | https://elifesciences.org/articles/46112 |